The following is a summary of “Cross-trait GWAS in COVID-19 and systemic sclerosis reveals novel genes implicated in fibrotic ...
Among the total systemic sclerosis cohort, 14% of individuals were categorized as frail and 53% as prefrail, with frailty status linked to an increased risk for mortality.
The following is a summary of “Foot peripheral sensory neuropathy: a frequent disabling manifestation in systemic sclerosis,” ...
Sildenafil was effective for reducing diastolic dysfunction and altered ejection fraction among patients with SSc.
Acute and chronic renal diseases remain common complications of systemic sclerosis. Although treatment for acute scleroderma renal crisis may arrest the rapid progression of renal disease ...
Which of the statements about the guideline for the screening and monitoring of interstitial lung disease among patients with systemic autoimmune rheumatic diseases are correct?
Cabaletta’s new data slice for its investigational CD19-CAR T cell therapy shows “robust benefit” for patients with lupus and ...
An expert review provides best practice advice on diagnostic considerations of immune-mediated disorders that should be ...
The FDA has accepted an investigational new drug application for ALLO-329, an allogeneic chimeric antigen receptor T-cell ...
Cabaletta Bio (NASDAQ:CABA – Get Free Report)‘s stock had its “buy” rating reissued by HC Wainwright in a note issued to ...
LUND, SE / ACCESS Newswire / February 19, 2025 /Cantargia AB (publ) ("Cantargia") (Nasdaq Stockholm:CANTA) today announced that members of Cantargia's management will participate in one-on-one ...
Tyr Pharma, Inc. (NASDAQ:ATYR), a clinical-stage biotechnology company valued at $286.24 million, is garnering attention from investors and analysts alike as it advances its lead candidate, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results